Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Somerville company aims to ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Apple informed developers today of an upcoming update to the minimum Software Development Kit (SDK) requirements for iOS, iPadOS, tvOS, visionOS, and watchOS apps. Here are the details. Apple has ...

Tom Fenton used AI-assisted vibe coding to create and deploy a free, cloud-hosted static web page. GitHub Pages provided a no-cost way to host static HTML content without servers, databases, or paid ...

Systems like OpenAI’s GPT-5 are accelerating research in math, biology and chemistry. But there is a debate over whether it can do that work on its own. Credit...Agnes Jonas Supported by By Cade Metz ...

Dec 31 (Reuters) - Trump Media and Technology Group (DJT.O), opens new tab said on Wednesday it will distribute a new digital token to its shareholders, deepening its push into digital assets as ...

Trump Media and Technology Group (DJT), the company behind Truth Social, said Wednesday it plans to distribute a new digital token to shareholders through a deal with Crypto.com. The token will be ...